Back to User profile » Prof. Dr. Tati Herlina
Papers published by Prof. Dr. Tati Herlina:
Synergistic Potential of Trikatu Essential Oil as an Aromatherapy Agent: A Chemical and Mechanistic Review
Pramitha DAI, Herlina T, Maksum IP, Hardianto A, Latip J
Drug Design, Development and Therapy 2025, 19:6751-6776
Published Date: 5 August 2025
Coumarins from Citrus aurantiifolia (Christm.) Swingle Peel with Potential Cytotoxic Activity Against MCF-7 Breast Cancer Cell Line: In Vitro and In Silico Studies
Julaeha E, Mulyawan FE, Anwar FM, Akili AWR, Permadi N, Darwati, Kurnia D, Herlina T
OncoTargets and Therapy 2025, 18:441-452
Published Date: 30 March 2025
Virtual Screening, Toxicity Evaluation and Pharmacokinetics of Erythrina Alkaloids as Acetylcholinesterase Inhibitor Candidates from Natural Products
Permana A, Akili AWR, Hardianto A, Latip JB, Sulaeman AP, Herlina T
Advances and Applications in Bioinformatics and Chemistry 2024, 17:179-201
Published Date: 5 February 2025
Investigating the Potency of Erythrina‒Derived Flavonoids as Cholinesterase Inhibitors and Free Radical Scavengers Through in silico Approach: Implications for Alzheimer’s Disease Therapy
Akili AWR, Thurfah NA, Hardianto A, Latip J, Herlina T
Advances and Applications in Bioinformatics and Chemistry 2024, 17:107-118
Published Date: 1 November 2024
Cytotoxic Evaluation, Molecular Docking, Molecular Dynamics, and ADMET Prediction of Isolupalbigenin Isolated from Erythrina subumbrans (Hassk). Merr. (Fabaceae) Stem Bark: Unveiling Its Anticancer Efficacy
Herlina T, Akili AWR, Nishinarizki V, Hardianto A, Sulaeman AP, Gaffar S, Julaeha E, Mayanti T, Supratman U, Nafiah MA, Latip JB
OncoTargets and Therapy 2024, 17:829-840
Published Date: 17 October 2024
Bioinformatics Study of Flavonoids From Genus Erythrina As Ace2 inhibitor Candidates For Covid-19 Treatment
Herlina T, Akili AWR, Nishinarizki V, Hardianto A, Latip J
Advances and Applications in Bioinformatics and Chemistry 2024, 17:61-70
Published Date: 14 May 2024
Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of S. sanguinis ATCC 10,556 and as Inhibitor of MurA Enzymes: in vitro and in silico Study
Kurnia D, Hutabarat GS, Windaryanti D, Herlina T, Herdiyati Y, Satari MH
Drug Design, Development and Therapy 2020, 14:2977-2985
Published Date: 27 July 2020